Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. Aug. 29, 2018. Christian Hoyer Millar.

Executive Summary

Oxford Biodynamics is making moves to enter the Chinese market after welcoming on board new investor and strategic partner GL Capital, a Shanghai-based private equity firm specializing in health care. See what company CEO Christian Hoyer Millar said about it here.

"China is a huge health-care market and one we wanted to address. We were approached by a number of different parties in China to sign as partners, but we chose GL primarily because it’s a focused health-care fund." –Christian Hoyer Millar, CEO, Oxford Biodynamics

Click here for a free trial of Medtech Insight

 
Advertisement

Related Content

Oxford Biodynamics Looks To Eastern Expansion With Chinese Investor

Topics

Advertisement
UsernamePublicRestriction

Register

MT123198

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel